Search results
We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This...
Simply Wall St. via Yahoo Finance· 3 days agoThis is something shareholders will keep in mind as they cast their votes on company resolutions...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 1 day agoAfter...me from Biogen,” Burkly said in an interview on the sidelines of the American Society of ...
Celebrity News | Entertainment News | TMZ.com
TMZ· 1 day agoArticles - July, 2018 Will Smith -- Good Genes or Good Docs? NBA Owner's Daughter Says Becky Hammon Will Change NBA Forever Sexy Canadian Stars ... Eh? MLB's Christian Yelich Buys $5.6 mil Malibu Beach Pad,
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool via Yahoo Finance· 1 day agoHe's obviously not alone in the accolades for Accolade. Wood sees this as a good entry point as...
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoErik Holmlin -- Chief Executive Officer Thank you, David, and good afternoon, everyone. We...
Impossible Foods CEO on the importance of first impressions
Food Dive via Yahoo Finance· 4 days agoImpossible says that it makes the ingredient by using a yeast genetically engineered with the gene...
Q1 2024 Editas Medicine Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoNow I will turn the call over to our CEO, Gilmore O’Neill. Gilmore O’Neill Thanks, Christy, and good morning, everyone. Thank you for joining us today.
Adam Carolla premiers new anti-woke show with Roseanne Barr, Megyn Kelly
Newsweek· 3 days agoCirca 1994, a wannabe comedian by the name of Adam Carolla was wondering how to get on radio and...
Q1 2024 Viatris Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoWe have an incredibly talented team. And we have clear plans to deliver on our key R&D objectives to support Viatris' overall growth. Now I will turn the call over to Doretta to work through ...
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.40
ETF DAILY NEWS· 15 hours agoTenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are covering the stock, Marketbeat.com reports. Canaccord Genuity ...
